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Proteins with death effector domains (DED) are key signal transducers involved in cell death and 
inflammation. In this issue of Cell, Sun et al. (2008) describe TIPE2, a DED protein that negatively 
regulates both T cell receptor and Toll-like receptor signaling. These findings reveal a new element 
critical to the maintenance of homeostasis in both the adaptive and innate immune systems.Homeostasis within the immune system 
is maintained by myriad mechanisms 
that include the regulation of immune 
cell activation and programmed cell 
death (Bidere et al., 2006). Altered regu-
lation of cell death or activation and 
expansion of immune cells disrupts 
homeostasis of the immune system, 
which may result in potentially lethal 
inflammatory diseases. A subfamily 
of proteins that contribute to immune 
homeostasis possesses a hexahelical 
bundle motif, called the death effector 
domain (DED). The DED is structurally 
related to the death domain (DD) and 
the caspase activation and recruitment 
domain (CARD), which are found in 
proteins participating in cell death and 
other signaling pathways (Tibbetts et al., 
2003). Homotypic interactions between 
DED proteins have been shown to regu-late programmed cell death triggered by 
activation of Fas and other death recep-
tors. For example, FADD links Fas to 
the cysteine proteases caspase-8 and 
caspase-10 through homotypic inter-
action between their DED domains to 
initiate apoptosis. By contrast, cellular 
and viral antiapoptotic DED proteins, 
known as FLIPs, inhibit Fas-induced 
death by interfering with FADD and 
caspase-8 (Table 1). However, it is now 
well accepted that several DED proteins 
also critically regulate cell proliferation 
in addition to cell death (Tibbetts et al., 
2003) (Table 1). In this issue, Sun et al. 
(2008) add to the growing list of DED-
containing proteins with their identifi-
cation of a new member called TIPE2 
(tumor necrosis factor-α-induced pro-
tein 8-like 2). These investigators show 
that TIPE2 governs immune homeo-Cestasis in both the innate and adaptive 
immune systems by negatively regu-
lating signaling by T cell receptors and 
Toll-like receptors (TLRs).
TIPE2 was initially identified as a gene 
abnormally expressed in the inflamed 
spinal cord of mice with experimental 
autoimmune encephalomyelitis (EAE), a 
model of multiple sclerosis. TIPE2 shares 
53% amino acid identity with tumor 
necrosis factor (TNF)-α-induced pro-
tein 8 (TNFAIP8), a DED protein that may 
regulate apoptosis. The authors showed 
that at 2 months of age, TIPE2-deficient 
mice developed progressive immune 
pathology characterized by weight loss, 
splenomegaly, leukocytosis, and multior-
gan inflammation leading to death. When 
challenged with bacterial (Listeria mono-
cytogenes) or viral (lymphocytic cho-
riomeningitis virus, LCMV) pathogens Table 1. DED Proteins and Their Functions in Cell Death and Immune Cell Activation
Protein
Binding to Other 
DED Proteins Role in Cell Death Nonapoptotic Role
TIPE2 Caspase-8 Positively regulates Fas- and TCR-
mediated death; not part of the DISC
Negatively regulates macrophage TLR2, TLR3, TLR4, and TLR9 signaling; 
TIPE2−/− mice are hypersensitive to LPS-induced septic shock
FADD Caspase-8, 
MC159, PEA-15
Connects the death receptors to 
caspase-8 and caspase-10 to form 
DISC and initiate apoptosis
Thymocyte development, T cell proliferation, and cell-cycle control;  
positively regulates TLR3 signaling and modulates TLR4 signaling
Caspase-8 FADD, PEA-15, 
FLIP, TIPE2
Recruited to the DISC through FADD 
and propagates apoptosis
Necessary for T cell, B cell, and NK cell proliferation and TLR2, TLR3, and 
TLR4 signaling in B cells; cooperates with FADD to promote cell-cycle 
progression in T cells
c-FLIPL FADD,  
Caspase-8
Competes with caspase-8 for binding 
to FADD within the DISC and nega-
tively regulates Fas killing
Involved in lymphocyte proliferation; cleaved by caspase-8 into an NF-κB 
activating fragment
c-FLIPS FADD,  
Caspase-8
Inhibits Fas killing Reduces lymphocyte proliferation, caspase-8 activation, and NF-κB in T 
cells from transgenic animals 
PEA-15 FADD,  
Caspase-8
Inhibits Fas killing Sequesters ERK1/2 in the cytosol and promotes ERK-dependent  
phosphorylation of RSK
K13 Blocks Fas in vitro but not in vivo; pro-
tects TF-1 leukemic cells from cytokine 
withdrawal-induced death 
Selectively activates NF-κB through binding to IKK; splenocytes from K13 
transgenic mice exhibit enhanced proliferation following TCR and TLR4 
stimulation; K13 transgenic mice present an increased risk of lymphomall 133, May 2, 2008 ©2008 Elsevier Inc. 401
prior to the development of spontaneous 
disease, TIPE2-deficient mice showed 
increased numbers of CD8+ T cells in 
the spleen and increased cytokine pro-
duction, suggesting that TIPE2 regu-
lates the T cell response. Consistent 
with this notion, TIPE2 was predomi-
nantly expressed in immune cells of the 
myeloid and lymphoid lineages. Notably, 
TIPE2 expression was also induced by 
the cytokine tumor necrosis factor alpha 
(TNF-α) in at least one fibroblast cell line, 
suggesting that TIPE2 may be expressed 
in many cell types to establish equilib-
rium during an inflammatory response. 
Intriguingly, there also exist two highly 
homologous and, as yet, uncharacter-
ized proteins, TIPE1 and TIPE3.
Sun and colleagues found that TIPE2 
played no role in B cell adaptive immunity 
but did modulate T cell receptor (TCR)-
mediated activation of T cells. Although 
T cells lacking TIPE2 were hyperactivated 
by TCR stimulation, there was no differ-
ence in their ability to proliferate com-
pared to wild-type T cells. Paradoxically, 
TIPE2 overexpression slightly repressed 
both lymphocyte activation and prolifera-
tion. These finding are intriguing given that 
lymphocyte proliferation is dramatically 
reduced in the absence of DED factors 
such as FADD, caspase-8, and cFLIPL 
(Chun et al., 2002; Zhang et al., 1998). 
In contrast, transgenic expression of the 
nonapoptotic DED factors FLIPL and FLIP 
K13 of human herpesvirus-8 promotes 
enhanced proliferation of lymphocytes 
(Chugh et al., 2005; Lens et al., 2002).
In the context of innate immunity, the 
authors found that TIPE2 negatively reg-
ulated the TLR signaling pathway. Mac-
rophages lacking TIPE2 or B cells stimu-
lated with several TLR ligands produced 
more of the cytokines interleukin-6 (IL-6) 
or TNF-α and IL-1β, respectively, than 
wild-type cells. A dramatic difference in 
survival was also observed between mice 
with and without TIPE2 that were treated 
with low-dose lipopolysaccharide (LPS) 
to induce septic shock. A common fea-
ture of these TLR signaling pathways is 
the formation of large multiprotein com-
plexes necessary for signal transduction, 402 Cell 133, May 2, 2008 ©2008 Elsevier Incand it is possible that TIPE2 may inte-
grate into these complexes. The intracel-
lular localization of TIPE2 in unstimulated 
and stimulated cells, as yet unexplored, 
could shed light on whether this is the 
mode of TIPE2 action.
How might these wide-ranging roles 
attributed to TIPE2 in modulating the 
immune response be mechanistically 
orchestrated? The authors first found 
that TIPE2 downregulated multiple sig-
naling pathways in macrophages stimu-
lated with LPS. Although TIPE2 did not 
target the extracellular signal-regulated 
kinase (ERK) pathway, it did repress 
activation of c-Jun N-terminal kinase 
(JNK) and p38 MAP kinase, resulting in 
diminished activity of the transcription 
factor AP-1. In addition, TIPE2 depletion 
led to increased nuclear translocation of 
the master transcription factor NF-κB 
subsequent to enhanced phosphory-
lation and degradation of its inhibitor 
IκBα. Sun et al. further found that a por-
tion of TIPE2 was constitutively associ-
ated with proapoptotic caspase-8 and 
proposed that TIPE2′s regulation of the 
NF-κB pathway may be mediated by this 
proapoptotic enzyme. However, it will be 
important to clarify the binding between 
TIPE2 and caspase-8 and to assess 
whether this interaction is an essential 
step in TIPE2 action.
Following on from their observation of 
TIPE2′s interaction with caspase-8, Sun 
et al. also discovered another facet of 
TIPE2 function in regulating cell death. 
TIPE2 knockdown inhibited Fas-medi-
ated apoptosis and antigen receptor-
induced cell death (AICD), which par-
tially involves Fas. In addition, ectopic 
expression of TIPE2 enhanced Fas-
mediated killing. Surprisingly, although 
TIPE2 binds to caspase-8, TIPE2 was 
not found in the death-inducing signal-
ing complex (DISC) following Fas ligation 
and did not impair FADD and caspase-8 
recruitment. This distinguishes TIPE2 
from previously characterized DED pro-
teins that bind to FADD or caspase-8 
and that alter the DISC. The mecha-
nism by which TIPE2 inhibits apoptosis 
remains an open question..DED proteins interact with many pro-
teins that do not contain DED domains. 
For example, the DED protein PEA-15 
associates with the ERK1/2 kinases to 
prevent their accumulation in the nucleus 
(Formstecher et al., 2001) and the K13 
DED protein binds to the IKK complex 
to promote the activation of NF-κB (Liu 
et al., 2002). Furthermore, odd bedfel-
lows such as FADD and CK1α, or cas-
pase-8 and TRAF6, seem to pair up in 
functionally important ways. Therefore, 
it is likely that TIPE2 has binding part-
ners that are not DED proteins. Defin-
ing these TIPE2-interacting partners will 
undoubtedly provide insights into how 
TIPE2 regulates immune signaling path-
ways. Although much work is required 
to fully elucidate how TIPE2 operates, 
the identification of this protein and 
the intriguing phenotype of the TIPE2-
deficient mice establish TIPE2 as an 
important factor in the maintenance of 
immune homeostasis.
REfEREncEs
Bidere, N., Su, H.C., and Lenardo, M.J. (2006). 
Annu. Rev. Immunol. 24, 321–352.
Chugh, P., Matta, H., Schamus, S., Zachariah, 
S., Kumar, A., Richardson, J.A., Smith, A.L., and 
Chaudhary, P.M. (2005). Proc. Natl. Acad. Sci. 
USA 102, 12885–12890.
Chun, H.J., Zheng, L., Ahmad, M., Wang, J., Speirs, 
C.K., Siegel, R.M., Dale, J.K., Puck, J., Davis, J., 
Hall, C.G., et al. (2002). Nature 419, 395–399.
Formstecher, E., Ramos, J.W., Fauquet, M., Calde-
rwood, D.A., Hsieh, J.C., Canton, B., Nguyen, X.T., 
Barnier, J.V., Camonis, J., Ginsberg, M.H., and Ch-
neiweiss, H. (2001). Dev. Cell 1, 239–250.
Lens, S.M., Kataoka, T., Fortner, K.A., Tinel, A., 
Ferrero, I., MacDonald, R.H., Hahne, M., Beer-
mann, F., Attinger, A., Orbea, H.A., et al. (2002). 
Mol. Cell. Biol. 22, 5419–5433.
Liu, L., Eby, M.T., Rathore, N., Sinha, S.K., Kumar, 
A., and Chaudhary, P.M. (2002). J. Biol. Chem. 
277, 13745–13751.
Sun, H., Gong, S., Carmody, R., Hilliard, A., Li, L., 
Sun, J., Kong, L., Xu, L., Hilliard, B., Hu, S., et al. 
(2008). Cell, this issue.
Tibbetts, M.D., Zheng, L., and Lenardo, M.J. 
(2003). Nat. Immunol. 4, 404–409.
Zhang, J., Cado, D., Chen, A., Kabra, N.H., and 
Winoto, A. (1998). Nature 392, 296–300.
